PCN60 Cost Effectiveness of Nilotinib, Dasatinib and Imatinib as First Line Treatment of Chronic Myeloid Leukemia in Colombia 2011
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.1177
https://www.valueinhealthjournal.com/article/S1098-3015(12)01242-9/fulltext
Title :
PCN60 Cost Effectiveness of Nilotinib, Dasatinib and Imatinib as First Line Treatment of Chronic Myeloid Leukemia in Colombia 2011
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)01242-9&doi=10.1016/j.jval.2012.03.1177
First page :
A218
Section Title :
Cancer
Open access? :
No
Section Order :
697